EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

Publisher Name :
Date: 15-May-2013
No. of pages: 46

Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of Neisseria meningitidis are classified based on the chemical composition of unique polysaccharide capsules. Although there are 13 different serogroups, nearly all disease in humans is caused by strains representative of six serogroups: A, B, C, W-135, X and Y (CDC, 2012d; Halperin et al., 2012; Rosenstein et al., 2001). Humans are the only natural reservoir of Neisseria meningitidis, and the bacterium causes three common clinical forms of meningococcal disease: meningitis, blood infection, and pneumonia (CDC, 2012d; Wilder-Smith and Memish, 2003). Up to 10% of adolescents and adults are asymptomatic, transient carriers of the bacterium, which can be transmitted via respiratory droplets or by direct contact (CDC, 2012d).

During the forecast period, the number of incident cases will remain relatively stable. An increase in international travel to regions of high incidence could cause some serogroups to appear in countries where they were not previously prevalent. In addition to vaccinating international travelers, the vaccination of household members of individuals traveling to high-risk regions would further prevent outbreaks due to strains that certain populations are not yet immune to.

GlobalData epidemiologists obtained surveillance data for each market in this analysis, except for Spain and the UK. However, for these markets a peer-reviewed journal article was used that analyzed the surveillance data in these countries. The surveillance data used in this analysis are collected by country-specific, governmental organizations that routinely collect data on meningococcal disease cases. Use of surveillance data is optimal as it allows for a comprehensive picture of the epidemiology of the disease, including age and serogroup distribution. Although the overall incidence of meningococcal disease is relatively low, the age and serogroup segmentation of incident cases provided in this forecast shows the populations at highest risk for meningococcal disease in each market.

Scope


  • The Meningococcal Disease EpiCast Report provides an overview of the risk factors and global trends of meningococcal disease in the eight major markets (US, France, Germany, Italy, Spain, UK, Australia, and Brazil).

  • It includes a 10-year epidemiology forecast of meningococcal disease incident cases segmented by age (<1, 1–4, 5–14, 15–24, 25–44, 45–64, and ending at ages 65 years and older) and serogroup (B, C, Y, and W-135) in the 8MM.


Reasons To Buy

  • Develop business strategies by understanding the trends shaping and driving the global meningococcal disease market.

  • Quantify patient populations in the global meningococcal disease market to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the age groups and serogroups that present the best opportunities for meningococcal disease vaccines in each of the markets covered.

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

Table Of Contents

1 Table of Contents 4
List Of Tables 6
List Of Figures 6

2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Reports 8

3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.2.1 Infants and young children are at greatest risk for developing meningococcal disease 10
3.2.2 Direct contact and overcrowding are the primary risk factors for infection 11
3.2.3 Exposure is highest for those traveling to the African "meningitis belt" 12
3.3 Global Trends 13
3.3.1 US 13
3.3.2 5EU 14
3.3.3 Australia 15
3.3.4 Brazil 16
3.4 Forecast Methodology 17
3.4.1 Sources Used 19
3.4.2 Forecast Assumptions and Methods 23
3.4.3 Sources Not Used 27
3.5 Epidemiology Forecast of Meningococcal Disease (2012-2022) 28
3.5.1 Incident Cases of Meningococcal Disease 28
3.5.2 Age-Specific Incident Cases of Meningococcal Disease 30
3.5.3 Incident Cases of Meningococcal Disease By Serogroup 32
3.6 Discussion 34
3.6.1 Conclusions on Epidemiological Trends 34
3.6.2 Limitations of the Analysis 35
3.6.3 Strengths of the Analysis 35

4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 43
4.2.1 Epidemiologists 43
4.2.2 Reviewers 43
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 44
4.2.4 Global Head of Healthcare 44
4.3 About GlobalData 45
4.4 About EpiCast 45
4.5 Contact Us 45
4.6 Disclaimer 46

List Of Tables

Table 1: Risk Factors for Meningococcal Disease 10
Table 2: Sources of Incidence Data Used in the Epidemiology Forecast 18
Table 3: 8MM, Incident Cases of Meningococcal Disease, N, Select Years, 2012-2022 28
Table 4: 8MM, Incident Cases of Meningococcal Disease, By Age, N (Row %), 2012 31
Table 5: 8MM, Incident Cases of Meningococcal Disease, By Serogroup, N (Row %), 2012 32

List Of Figures

Figure 1: 8MM, Incident Cases of Meningococcal Disease, N, Select Years, 2012-2022 29
Figure 2: 8MM, Incident Cases of Meningococcal Disease, By Age, N, 2012 31
Figure 3: 8MM, Incident Cases of Meningococcal Disease, By Serogroup, %, 2012 33

  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Surgical Robots Market 2016 Updates on Companies, Products and More
    Surgical robots are medical devices that assist surgeons in performing many types of complex procedures with more accuracy, flexibility and control than is possible with conventional techniques. The aim of surgical robots market players is to provide improved diagnostic skills, a less invasive and more comfortable experience for the patient, and the ability to do [...]
  • International Wound Cleanser Industry 2019 Forecasts with Feasibility Study of Future Projects
    ‘Market Research Report on Global and Chinese Wound Cleanser Industry, 2009-2019’ is a comprehensive market research report that offers top-notch industry insights and analyzes the growth prospects of the industry, along with evaluating the up-surging opportunities in the Global and Chinese market over the forecast period of 2014-2019. The methodically planned sections of the research [...]
  • United States Cephalosporin Drug Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 3800 Onwards        Pages: 130
    The United States Cephalosporin Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Cephalosporin Drug industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cephalosporin Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.......
  • Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 2800 Onwards        Pages: 157
    The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections market analysis is provided......
  • Global Cytomegalovirus Therapeutic Industry 2016 Market Research Report
    Published: 13-Jun-2016        Price: US 2800 Onwards        Pages: 154
    The Global Cytomegalovirus Therapeutic Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Cytomegalovirus Therapeutic industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cytomegalovirus Therapeutic market analysis is provided for the international market including development history, competitive landscape analysis, and major......
  • Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Market Professional Survey Report 2016
    Published: 08-Jun-2016        Price: US 3500 Onwards        Pages: 114
    This report mainly covers the following Product types including Vancomycin Linezolid Quinupristin/dalfopristin Daptomycin Tigecycline Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India The players list (Partly, Players you are interested in can also be added) Pfizer......
  • Global Niclosamide Market Professional Survey Report 2016
    Published: 07-Jun-2016        Price: US 3500 Onwards        Pages: 108
    This report mainly covers the following Product types including Tablet Capsule Injection The segment applications including Hospital use Clinic use Household Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India The players list (Partly, Players you are interested......
  • EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2025
    Published: 01-Jun-2016        Price: US 3995 Onwards        Pages: 82
    EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2025 Summary Invasive meningococcal disease (IMD) is a life-threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis), an encapsulated gram-negative diplococcus that is a pathogen exclusive to humans. N. meningitidis is carried harmlessly in the nasopharynx of approximately 5?11% of adults and up to 25% of adolescents. Life-threatening disease occurs when the bacterium inva......
  • Global Voriconazole Market Professional Survey Report 2016
    Published: 31-May-2016        Price: US 3500 Onwards        Pages: 177
    This report Mainly covers the following product types Injection Freeze-dried powder The segment applications including Hospital use Clinic Others Segment regions including (the separated region report can also be offered) USA China UK France Switzerland Japan Germany India The players list (Partly, Players you are interested in......
  • Hand, Foot And Mouth Disease - Pipeline Review, H1 2016
    Published: 31-May-2016        Price: US 2000 Onwards        Pages: 33
    Hand, Foot And Mouth Disease - Pipeline Review, H1 2016 Summary Global Markets Direct's, ‘Hand, Foot And Mouth Disease - Pipeline Review, H1 2016', provides an overview of the Hand, Foot And Mouth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hand, Foot And Mouth Disease , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration ......
  • Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2016
    Published: 31-May-2016        Price: US 2000 Onwards        Pages: 62
    Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2016 Summary Global Markets Direct's, ‘Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2016', provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Burkholderia pseudomallei Infections (Melioidosis), complete with analysis by......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs